J9047 Carfilzomib - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Carfilzomib

Brand Name:

Kyprolis

Strength:

1 mg

HCPCS:

J9047

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Proteasome Inhibitor

Minor Drug Class:

20S

Oral (Y/N):

No

FDA Approval Year:

2012

FDA Discontinuation Year:

CMS Effective Date:

April 1, 2014

CMS Discontinuation Date:

Status:

In Use